Biotech money shock: Investors unwind speculative bets as pandemic fears fade
While an appetite for the shares of vaccine makers and drug companies remain, inflows into health care funds have slowed to more modest figures.
Desperate U.S. bids to engineer corals resistant to climate change
Global warming worries have reached the point where scientists are trying to tweak some organisms' genetics so that they might survive.
SoftBank built a $5 billion stake in pharma giant Roche
Roche's diagnostics unit reacted swiftly to the pandemic, and now sales are boosted by its COVID-19 testing business.
A fairer world requires fairer tech. Here’s why.
In the decade ahead, a wave of technological solutions will touch and transform every part of our lives. These new solutions could either tackle existing problems — or exacerbate them while creating others. As tech can scale both progress or harm, the time is ...
Biotech future of promise and peril looms larger and closer
Emerging technology poses new and novel questions. Unfortunately, the time to answer them is growing short.
Japan team uses stem cells to spawn 1,700 trout from single fish
The researchers hope to apply the technique to bluefin tuna within around five years.
Japan's AnGes speeds toward 2021 rollout in coronavirus 'vaccine war'
The Osaka-based firm got a headstart in the vaccine development by repurposing its hypertension vaccine, which had already passed various safety hurdles.
Japan researchers create tiny bronchi to develop drug for COVID-19
It is hoped the miniature organ will serve as a better model for evaluating anti-viral drugs' efficacy than a single cell.
Japanese researchers to test blood thinner for coronavirus treatment
A blood thinner used to treat pancreatitis and kidney disease has been identified as a potential therapy for COVID-19 patients, with clinical trials in Japan possibly set to begin within a month, researchers at the University of Tokyo said Wednesday. The drug, known by the ...
Lab-grown meat? Dutch start-up keeps pork on your plate without wrecking the planet
A Dutch start-up may have found a workaround for eco-conscious consumers struggling to give up meat: pork grown in a laboratory that doesn't harm animals or damage the planet. Meatable will this summer unveil its first pork prototype made entirely from cultured animal cells instead ...
Osaka University transplants iPS cell-based heart cells in world's first clinical trial
An Osaka University team said it has carried out the world's first transplant of cardiac muscle cells created from iPS cells in a physician-initiated clinical trial. In the clinical project to verify the safety and efficacy of the therapy using induced pluripotent stem cells, Yoshiki ...
An expert panel of the health ministry on Friday approved a clinical research program proposed by a Kyoto University team to transplant cartilage made from induced pluripotent stem (iPS) cells to damaged knee joints. Professor Noriyuki Tsumaki and other members of the team are planning ...
